Call to arrange a consultation
+1 416 777 0888
Search the site
Actelion Pharmaceuticals Ltd. et al v. Sandoz Canada Inc.
2022
T-1750-22
Pending
New PM(NOC) Regulations
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,731,370 and 2,764,475 (selexipag).
Counsel to:
Sandoz Canada Inc.
The decision is reported
here.
Meet the team
